Voyager Therapeutics Inc (VYGR)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $107.66M
Last updated: Nov 17, 2026 at 4:38 PM ET
Voyager Therapeutics Inc (VYGR) Stock Chart
Voyager Therapeutics (VYGR) has a latest price of $1.52 on Nov 17, 2026. Its price fell 61.3% over the past 12 months. The month-end price fell 85.7% over the 10 years through Oct 2026, a compound annual decline of 17.7%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $28.73 in Feb 2018 and its lowest $1.72 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart VYGR with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for VYGR.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 55.4%, and over 6 months it fell 56.3%. The month-end price fell 73.8% over the 3 years through Oct 2026, a compound annual decline of 36.0%.
| Period | Change |
|---|---|
| 1 month | -25.9% |
| 3 months | -55.4% |
| 6 months | -56.3% |
| 12 months | -61.3% |
| 12 months, with dividends | -61.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -73.8% | -36.0% |
| 5 years | -52.5% | -13.8% |
| 10 years | -85.7% | -17.7% |
Price by Year
Its best calendar year was 2022, when the price rose 125.1%, and its weakest was 2021, when it fell 62.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.72 | -56.2% |
| 2025 | $3.93 | -30.7% |
| 2024 | $5.67 | -32.8% |
| 2023 | $8.44 | +38.4% |
| 2022 | $6.10 | +125.1% |
| 2021 | $2.71 | -62.1% |
| 2020 | $7.15 | -48.7% |
| 2019 | $13.95 | +48.4% |
| 2018 | $9.40 | -43.4% |
| 2017 | $16.60 | +30.3% |
Trading Range
The price is 34.1% below its 50-day average of $2.31 and 54.3% below its 200-day average of $3.33.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.52 | |
| 50-day average | $2.31 | -34.1% |
| 200-day average | $3.33 | -54.3% |
Price Risk
Over 3 years, its largest fall from a peak was 86.0%.
| Measure | Value |
|---|---|
| 1-year beta | 1.52 |
| Largest fall, 1 year | -69.6% |
| Largest fall, 3 years | -86.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About VYGR
What is VYGR's 1-year price change?
Voyager Therapeutics's price fell 61.3% over the past 12 months. With dividends included, the 12-month total return was -61.3%.
What is VYGR's 5-year price change?
Voyager Therapeutics's month-end price fell 52.5% over the 5 years through Oct 2026, a compound annual decline of 13.8%. These figures leave out dividends.
What is VYGR's beta?
Voyager Therapeutics's 1-year beta against the S&P 500 is 1.52, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 69.6%.
Is the VYGR chart free?
Yes. Advanced Charting for VYGR is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
VYGR pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors